Can metagenomics unravel the impact of oral bacteriome in human diseases?
- 21 July 2022
- journal article
- review article
- Published by Taylor & Francis in Biotechnology and Genetic Engineering Reviews
- Vol. 39 (1) , 85-117
Abstract
Oral microbial ecosystems are vital in maintaining the health of the oral cavity and the entire body. Oral microbiota is associated with the progression of oral diseases such as dental caries, periodontal diseases, head and neck cancer, and several systemic diseases such as cardiovascular disease, rheumatoid arthritis, adverse pregnancy outcomes, diabetes, lung infection, colorectal cancer, and pancreatic cancer. Buccal mucosa, tongue dorsum, hard palate, saliva, palatine tonsils, throat, keratinized gingiva, supra-gingival plaque, subgingival plaque, dentures, and lips are microbial habitats of the oral cavity. Porphyromonas gingivalis may have a role in the development of periodontal diseases, oral cancer, diabetes, and atherosclerotic disease. Fusobacterium nucleatum showed a higher abundance in periodontal diseases, oral and colon cancer, adverse pregnancy outcomes, diabetes, and rheumatoid arthritis. The higher abundance of Prevotella intermedia is typical in periodontal diseases, rheumatoid arthritis, and adverse pregnancy outcome. S. salivarius displayed higher abundance in both dental caries and OSCC. Oral bacteria may influence systemic diseases through inflammation by releasing pro inflammatory cytokines. Identification of oral bacteria using culture-dependent approaches and next-generation sequencing-based metagenomic approaches is believed to significantly identify the therapeutic targets and non-invasive diagnostic indicators in different human diseases. Oral bacteria in saliva could be exploited as a non-invasive diagnostic indicator for the early detection of oral and systemic disorders. Other therapeutic approaches such as the use of probiotics, green tea polyphenol, cold atmospheric plasma (CAP) therapy, antimicrobial photodynamic therapy, and antimicrobial peptides are used to inhibit the growth of biofilm formation by oral bacteria.Keywords
Funding Information
- MOSTI (R.J130000.7351.4B746)
This publication has 114 references indexed in Scilit:
- The human microbiome: at the interface of health and diseaseNature Reviews Genetics, 2012
- Distinct and complex bacterial profiles in human periodontitis and health revealed by 16S pyrosequencingThe ISME Journal, 2011
- Genomic analysis identifies association of Fusobacterium with colorectal carcinomaGenome Research, 2011
- The Relationship of the Oral Microbiotia to Periodontal Health and DiseaseCell Host & Microbe, 2011
- Invasive potential of gut mucosa-derived fusobacterium nucleatum positively correlates with IBD status of the hostInflammatory Bowel Diseases, 2011
- The oral metagenome in health and diseaseThe ISME Journal, 2011
- Human oral, gut, and plaque microbiota in patients with atherosclerosisProceedings of the National Academy of Sciences, 2010
- Oral multispecies biofilm development and the key role of cell–cell distanceNature Reviews Microbiology, 2010
- Term Stillbirth Caused by Oral Fusobacterium nucleatumObstetrics & Gynecology, 2010
- The Oral Microbiota: Living with a Permanent GuestDNA and Cell Biology, 2009